[1]
Harshini, D. et al. 2020. Therapeutic Considerations for Docetaxel and Paclitaxel in Metastatic Breast Cancer. Journal of Drug Delivery and Therapeutics. 10, 1-s (Feb. 2020), 196–204. DOI:https://doi.org/10.22270/jddt.v10i1-s.3852.